Abstract
Background
To date, the survival benefit of redo surgery in locally recurrent rectal adenocarcinoma remains unclear.
Study Design
In an institutional study, operations for recurrence were retrospectively analyzed. Survival was calculated using the Kaplan–Meier plot and Cox regression analysis.
Results
A total of 72 patients with local recurrence were explored or resected. In 38 patients, there was synchronous distant organ recurrence. Forty-five of 72 were re-resected and in 37 of 45 cases, R0 situations were achieved. In 11 of 38 metastasized patients, both local and distant organ recurrence were successfully removed. For obtaining tumor control, resections of inner genitals, bladder, and sacral bone were necessary in 10, 4, and 11 patients, respectively. Survival was better for patients re-resected with a median overall survival of 54.9 months, as compared with 31.1 months among non-resected patients (p = 0.0047, log-rank test). Subgroup analysis revealed that a benefit of re-resection was observed to a lesser extent in synchronous local and in distant disease. Cox analysis showed that initial Dukes stage and complete resections of local recurrences were independently determining prognosis (relative risk 1.762 and 0.689, p = 0.008 and p = 0.002, respectively).
Conclusions
Radical surgery for local recurrence can improve survival if complete tumor clearance is achieved, and concomitant distant tumor load should not principally preclude re-resection.
Similar content being viewed by others
Reference
Tschmelitsch J, Kronberger P, Prommegger R, Reibenegger G, Glaser K, Bodner E. Survival and local recurrence after anterior resection and abdominoperineal excision for rectal cancer. Eur J Surg Oncol 1995;21(6):640–643 (December).
Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351(17):1731–1740 (October 21).
Visser O, Bakx R, Zoetmulder FA, Levering CC, Meijer S, Slors JF et al. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in greater Amsterdam. J Surg Oncol 2007;95:447–454 (October 17).
Heald RJ. Local recurrence of rectal cancer. Dis Colon Rectum 1987;30(7):572 (July).
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345(9):638–646 (August 30).
Compton CC, Henson DE, Hutter RV, Sobin LH, Bowman HE. Updated protocol for the examination of specimens removed from patients with colorectal carcinoma. A basis for checklists. Arch Pathol Lab Med 1997;121(12):1247–1254 (December).
Compton CC. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: a basis for checklists. Cancer Committee. Arch Pathol Lab Med 2000;124(7):1016–1025 (July).
Compton CC. Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med 2006;130(3):318–324 (March).
Dent OF, Haboubi N, Chapuis PH, Chan C, Lin BP, Wong SK et al. Assessing the evidence for an association between circumferential tumour clearance and local recurrence after resection of rectal cancer. Colorectal Dis 2007;9(2):112–121 (February).
Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351(4):337–345 (July 22).
Read TE, Mutch MG, Chang BW, McNevin MS, Fleshman JW, Birnbaum EH et al. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon. J Am Coll Surg 2002;195(1):33–40 (July).
Wiggers T, de Vries MR, Veeze-Kuypers B. Surgery for local recurrence of rectal carcinoma. Dis Colon Rectum 1996;39(3):323–328 (March).
Khera G, Walsh CJ, Anderson JA, El-Sayed TY, Haylock BJ, Myint AS et al. Local recurrence after curative resection for rectal cancer—role of the multi-disciplinary team. Colorectal Dis 2007;9(2):187 (February).
Melton GB, Paty PB, Boland PJ, Healey JH, Savatta SG, Casas-Ganem JE et al. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum 2006;49(8):1099–1107 (August).
Swedish Rectal Cancer Trial. Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Eur J Surg 1996;162(5):397–402 (May).
Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336(14):980–987 (April 3).
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345(9):638–646 (August 30).
Rodel C, Sauer R. Neoadjuvant radiotherapy and radiochemotherapy for rectal cancer. Recent Results Cancer Res 2005;165:221–230.
Hansen MH, Kjaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg 2007;94(1):113–118 (January).
Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351(17):1731–1740 (October 21).
Nagtegaal ID, van de Velde CJH, Marijnen CA, van Krieken JH, Quirke P. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005;23(36):9257–9264 (December 20).
Kapiteijn E, van de Velde CJH. Developments and quality assurance in rectal cancer surgery. Eur J Cancer 2002;38(7):919–936 (May).
Havenga K, Enker WE, Norstein J, Moriya Y, Heald RJ, van Houwelingen HC et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol 1999;25(4):368–374 (August).
Kapiteijn E, Kranenbarg EK, Steup WH, Taat CW, Rutten HJ, Wiggers T, Dutch ColoRectal Cancer Group et al. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Eur J Surg 1999;165(5):410–420 (May).
Maas CP, Moriya Y, Steup WH, Kiebert GM, Kranenbarg WM, van de Velde CJH. Radical and nerve-preserving surgery for rectal cancer in The Netherlands: a prospective study on morbidity and functional outcome. Br J Surg 1998;85(1):92–97 (January).
Hahnloser D, Nelson H, Gunderson LL, Hassan I, Haddock MG, O’Connell MJ et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003;237(4):502–508 (April).
Melton GB, Paty PB, Boland PJ, Healey JH, Savatta SG, Casas-Ganem JE et al. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum 2006;49(8):1099–1107 (August).
Griffin MR, Bergstralh EJ, Coffey RJ, Beart RW Jr., Melton LJ III. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 1987;60(9):2318–2324 (November 1).
Sigurdsson HK, Korner H, Dahl O, Skarstein A, Soreide JA. Clinical characteristics and outcomes in patients with advanced rectal cancer: a national prospective cohort study. Dis Colon Rectum 2007;50:285–288 (January 22).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schurr, P., Lentz, E., Block, S. et al. Radical Redo Surgery for Local Rectal Cancer Recurrence Improves Overall Survival: A Single Center Experience. J Gastrointest Surg 12, 1232–1238 (2008). https://doi.org/10.1007/s11605-008-0517-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-008-0517-8